We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M Turnover 17.39%
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
-5.56%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$168M
AUM Growth
-$23.1M
Cap. Flow
-$10.3M
Cap. Flow %
-6.1%
Top 10 Hldgs %
59.36%
Holding
73
New
14
Increased
9
Reduced
26
Closed
17
Avg Time Held Equity + Options
0.8 years
Top 10 Avg Time Held Equity + Options
0.9 years
Top 20 Avg Time Held Equity + Options
0.9 years
Avg Time Held Equity only
0.8 years
Top 10 Avg Time Held Equity only
0.9 years
Top 20 Avg Time Held Equity only
0.9 years

Top Buys

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$5.13M
2
GS icon
Goldman Sachs
GS
+$3.86M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$1.89M
4
JPM icon
JPMorgan Chase
JPM
+$1.64M
5
ZVRA icon
Zevra Therapeutics
ZVRA
+$1.4M

Sector Composition

Rank Sector Weight
1 Healthcare 60.6%
2 Financials 9.03%
3 Miscellaneous 7.34%
4 Communication Services 6.38%
5 Materials 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CVS icon
1
CVS Health
CVS
$102B
$15.8M 9.36%
151,835
-66,096
-30% -$6.43M
2013 Q2
11 quarters
CAH icon
2
Cardinal Health
CAH
$62.9B
$14.8M 8.77%
180,196
-45,009
-20% -$3.66M
2013 Q2
11 quarters
ZVRA icon
3
Zevra Therapeutics
ZVRA
$540M
$13M 7.7%
55,847
+5,768
+12% +$1.4M
2015 Q2
3 quarters
FOMX
4
DELISTED
Foamix Pharmaceuticals
FOMX
$9.7M 5.79%
1,494,399
+85,802
+6% +$553K
2014 Q3
6 quarters
GS icon
5
Goldman Sachs
GS
$244B
$8.67M 5.15%
55,216
+24,934
+82% +$3.86M
2015 Q3
2 quarters
BERY icon
6
DELISTED
Berry Global Group
BERY
$8.32M 4.94%
250,470
-10,701
-4% -$312K
2015 Q3
2 quarters
HCA icon
7
HCA Healthcare
HCA
$96.2B
$8.26M 4.91%
105,875
-357
-0.3% -$24.9K
2014 Q4
5 quarters
NEOS
8
DELISTED
Neos Therapeutics
NEOS
$7.48M 4.45%
693,582
-245,016
-26% -$2.58M
2015 Q3
2 quarters
NSTG
9
DELISTED
NanoString Technologies
NSTG
$7.08M 4.2%
465,000
– –
2015 Q2
3 quarters
SWFT
10
DELISTED
Swift Transportation
SWFT
$6.92M 4.11%
371,293
-208,707
-36% -$3.38M
2015 Q3
2 quarters
ELV icon
11
Elevance Health
ELV
$84.3B
$6.27M 3.73%
45,129
+129
+0.3% +$17.2K
2013 Q2
11 quarters
APTV icon
12
Aptiv
APTV
$7.56B
$5.63M 3.34%
+75,000
New +$5.13M
2016 Q1
0 quarters
PFNX
13
DELISTED
Pfenex
PFNX
$4.92M 2.92%
500,000
+15,191
+3% +$133K
2014 Q3
6 quarters
PARA icon
14
DELISTED
Paramount Global Class B
PARA
$4.68M 2.78%
85,000
– –
2015 Q4
1 quarter
PRAA icon
15
PRA Group
PRAA
$426M
$4.64M 2.75%
157,718
-114,282
-42% -$3.29M
2015 Q3
2 quarters
BIIB icon
16
Biogen
BIIB
$36.5B
$3.67M 2.18%
14,089
-22
-0.2% -$5.81K
2015 Q4
1 quarter
DVAX icon
17
DELISTED
Dynavax Technologies
DVAX
$2.98M 1.77%
155,000
– –
2015 Q2
3 quarters
TWX
18
DELISTED
Time Warner
TWX
$2.75M 1.63%
37,922
-12,521
-25% -$862K
2015 Q4
1 quarter
SUN icon
19
Sunoco
SUN
$11.8B
$2.48M 1.48%
75,000
– –
2015 Q3
2 quarters
ACAD icon
20
Acadia Pharmaceuticals
ACAD
$3.04B
$2.31M 1.37%
82,500
+17,500
+27% +$382K
2015 Q1
4 quarters
AMGN icon
21
Amgen
AMGN
$237B
$2.29M 1.36%
15,303
-74
-0.5% -$11K
2013 Q2
11 quarters
MSFT icon
22
Microsoft
MSFT
$3.7T
$2.02M 1.2%
36,655
-9,833
-21% -$515K
2014 Q2
7 quarters
QQQ icon
23
Invesco QQQ Trust
QQQ
$418B
$1.99M 1.18%
+18,183
New +$1.89M
2016 Q1
0 quarters
SPY icon
24
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$732B
$1.76M 1.04%
762,500
-537,500
-41% -$105M
2014 Q1
8 quarters
JPM icon
25
JPMorgan Chase
JPM
$850B
$1.66M 0.99%
+28,078
New +$1.64M
2016 Q1
0 quarters

Similar funds

DSC Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, DSC Advisors held 73 positions worth $168M, down 12% from $191M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

DSC Advisors withdrew a net $10.3M in Q1 2016, closing 17 positions and reducing 26 holdings. Its most notable exit was Accelerate Diagnostics, an estimated $2.45M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, down from 67% a quarter earlier, followed by Financials and Miscellaneous.

Against the trend, DSC Advisors opened a new position in Aptiv worth $5.63M.

  • DSC Advisors's largest Q1 2016 buy was Aptiv: 75,000 shares worth $5.63M.
  • DSC Advisors added most to Goldman Sachs in Q1 2016, an estimated $3.86M increase.
  • DSC Advisors's biggest Q1 2016 reduction was CVS Health, cutting an estimated $6.43M.
  • DSC Advisors fully exited Accelerate Diagnostics in Q1 2016, selling an estimated $2.45M.
  • DSC Advisors's ten largest holdings make up 59% of its $168M portfolio in Q1 2016.
  • DSC Advisors opened 14 new positions and closed 17 in Q1 2016.
  • DSC Advisors's portfolio value fell 12% quarter-over-quarter to $168M.

Based on DSC Advisors's 13F filing for Q1 2016, filed 16 May 2016.